InvestorsHub Logo
Followers 33
Posts 2840
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Monday, 03/27/2023 4:34:05 PM

Monday, March 27, 2023 4:34:05 PM

Post# of 265
VRTX has signed a licensing deal to accelerate development of its hypoimmune cell therapies for the treatment of T1D https://www.fiercebiotech.com/biotech/vertex-goes-back-crispr-well-paying-100m-upfront-exa-cel-partner-help-diabetes-work
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News